Close Menu

NEW YORK – Qiagen on Wednesday afternoon reported preliminary second quarter financial results ahead of its full Q2 earnings release next week, and said that it is adjusting its full-year financial targets downward due to lower-than-expected sales of its sequencing products in China.

In Q2, Qiagen's net sales rose 1 percent year over year to $381.6 million from $377.2 million a year ago, and grew 5 percent at constant exchange rates (CER), in line with a previously provided outlook.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.